Hims & Hers Health
HIMS
154 hedge funds and large institutions have $643M invested in Hims & Hers Health in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 13 closing their positions.
115% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 13
111% more call options, than puts
Call options by funds: $10.2M | Put options by funds: $4.84M
61% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 33
30% more capital invested
Capital invested by funds: $497M → $643M (+$147M)
11% more funds holding
Funds holding: 139 → 154 (+15)
2.73% more ownership
Funds ownership: 55.27% → 58% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$9.05M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$8.99M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.74M |
| 4 |
Millennium Management
New York
|
+$4.05M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.6M |
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$6.25M |
| 2 |
Renaissance Technologies
New York
|
-$2.68M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.16M |
| 4 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$1.4M |
| 5 |
HF
HRT Financial
New York
|
-$1.37M |
HIMS Hedge Fund Activity: Q3 2022 in Review
154 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q3 2022, worth a combined $643M — up 30% from $497M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new HIMS positions and 13 closed out — a net gain of 15 holders — while 53 added to existing stakes and 33 trimmed.
The largest buyer was Nuveen, adding an estimated $9.05M. The largest seller was J. Goldman & Co, cutting an estimated $6.25M.
- 154 institutional investors held Hims & Hers Health (HIMS) as of Q3 2022, up from 139 in Q2 2022.
- Funds reported $643M of Hims & Hers Health stock for Q3 2022, up 30% quarter-over-quarter.
- 28 funds opened new Hims & Hers Health positions in Q3 2022 and 13 closed out, a net change of +15 holders.
- The largest Hims & Hers Health buyer in Q3 2022 was Nuveen, an estimated $9.05M added.
- The largest Hims & Hers Health seller in Q3 2022 was J. Goldman & Co, an estimated $6.25M sold.
Based on aggregated 13F filings for Q3 2022.